2022
DOI: 10.3390/pharmaceutics14112315
|View full text |Cite
|
Sign up to set email alerts
|

Ultra-Fast Middle-Up Reversed Phase Liquid Chromatography Analysis of Complex Bispecific Antibodies Obtained in Less Than One Minute

Abstract: This work illustrates the benefits and limitations of using ultra-short reversed phase liquid chromatography (RPLC) columns for the characterization of various complex bispecific antibodies after prolonged thermal stress at the middle-up level of analysis. First, we have demonstrated that alternative organic modifiers, such as isopropanol, can be used in RPLC mode without generating excessive pressure, thanks to the prototype 10 × 2.1 mm, 2.7 µm particle column. However, compared to acetonitrile, the selectivi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…Nonetheless, it should be noted that almost all the work published so far is based on the use of a large amount of starting material (a few micrograms), which is not sustainable for the analysis of in vivo biotransformation products. Improvements in stationary phases [49][50][51][52][53][54][55], low-flow chromatography, and alternative front-end separations [56][57][58] have recently opened the way to higher sensitivity studies. For instance, both the qualitative and quantitative top-down and middle-down analysis of biotherapeutics extracted from plasma has been described in the last years [59][60][61][62][63].…”
Section: Significance Statementmentioning
confidence: 99%
“…Nonetheless, it should be noted that almost all the work published so far is based on the use of a large amount of starting material (a few micrograms), which is not sustainable for the analysis of in vivo biotransformation products. Improvements in stationary phases [49][50][51][52][53][54][55], low-flow chromatography, and alternative front-end separations [56][57][58] have recently opened the way to higher sensitivity studies. For instance, both the qualitative and quantitative top-down and middle-down analysis of biotherapeutics extracted from plasma has been described in the last years [59][60][61][62][63].…”
Section: Significance Statementmentioning
confidence: 99%